This inventor holds 3 USPTO granted patents. Top assignees: Florida A&M University, The United States Government as Represented by the Department of Veterans Affairs, University of Michigan. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2017-2019
Title: Innovations of Arun Rishi in Cancer Treatment
Introduction
Arun Rishi is an accomplished inventor based in Detroit, MI (US). He has made significant contributions to the field of cancer treatment through his innovative formulations. With a total of 3 patents, Rishi's work focuses on enhancing drug delivery systems for better therapeutic outcomes.
Latest Patents
Rishi's latest patents include a self-emulsifying formulation of CARP-1 functional mimetics. This solid self-micro/nano emulsifying formulation comprises CARP-1 functional mimetics (CFM; e.g., CFM-4.16 or CFM-4.17) designed for oral administration. The methods of fabrication and use of this formulation aim to treat various types of cancer, including breast cancer, triple-negative breast cancer, resistant lung cancer, and non-resistant lung cancer. The formulation has been found to significantly enhance drug loading, aqueous solubility, and oral bioavailability, thereby reducing tumor volume.
Career Highlights
Throughout his career, Arun Rishi has worked with notable institutions such as Florida A&M University and Wayne State University. His research has focused on developing innovative solutions to complex medical challenges, particularly in oncology.
Collaborations
Rishi has collaborated with several professionals in his field, including Mandip Singh Sachdeva and Ketankumar Patel. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Arun Rishi's innovative work in cancer treatment through self-emulsifying formulations showcases his dedication to improving patient outcomes. His contributions to the field are significant and continue to inspire further research and development in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile